Human CD4+ CAR-T cells demonstrated similar findings: an increase in central memory T cells, sustained antitumor efficacy under hypoxia, and prolonged cytokine secretion when cocultured with EGFRvIII-positive tumor cells under hypoxic conditions (Supplemental Figure 8, A–D). This evidence concerns the gene CD4 and neoplasm.